E-Therapeutics PLC financial statements, including revenue, expenses, profit, and loss

The total revenue of ETXPF for the last semiannual is 200.44 k USD, and it's 2.41% lower compared to the previous semiannual. The net income of H2 23 is -7.07 M USD.